27 results
Thumbnail

D3.100 - Assessment of the impact of psychotropic drugs, antihistamines, and corticosteroids on the interpretation of skin tests in allergology

Thumbnail

D3.101 - Etoricoxib Associated Fixed Drug Eruption: A Case Series from a Tertiary Allergy and Clinical Immunology Centre, United Arab Emirates

Thumbnail

D3.93 - Clinical Efficacy of Tezepelumab in a Patient with Severe Refractory Mixed Asthma: A Case Report from Kazakhstan

Thumbnail

D3.106 - Real-life outcomes of rapid drug desensitization to taxanes

Thumbnail

D3.94 - Good Practice Recommendations for Basophil Activation Test (BAT) Data Analysis in Routine and High-Background Settings

Thumbnail

D3.95 - Hidden in everyday cosmetics: Facial allergic contact dermatitis to fragrances

Thumbnail

D3.96 - High burden of latent aeroallergen sensitization in healthy urban medical students: a blinded skin prick test study from South India

Thumbnail

D3.97 - Allergic contact dermatitis confirmed by repeated open application test in a 68‑year‑old patient

Thumbnail

D3.98 - An extended study for the multiple detection of IgE-mediated allergic reactions using microarray technology

Thumbnail

D3.104 - Molecular Co-Sensitization Mapping Using a 192-Line Multiplex IgE Platform

Thumbnail

D3.105 - Analysis of post-vaccination immunity in children with dermatology diseases receiving biologic and immunosuppressive therapy

Thumbnail

D3.107 - Comparison of Cupressaceae sensitization allergens in a large Spanish cohort

Thumbnail

D3.103 - Comprehensive Allergen Characterization for Standardized Basophil Activation Testing

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials

Thumbnail

D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use

Thumbnail

D2.453 - Olfactory outcomes of dupilumab in patients with CRSwNP: A real-world prospective study